Americas Watchdog Initiates a National Investigation of Possible Victims of the Drug Called Trasylol

Share Article

Americas Watchdog & its Corporate Whistle Blower Center are initiating a national investigation involving possible victims of the drug Trasylol. The subject of numerous news casts and law suits; Trasylol has been linked to possible deaths and serious injuries that could involve thousands of US Citizens. The Americas Watchdog seeks to talk with possible victims or their families about Trasylol, and what might have happened to individuals who were given this pharmaceutical. The group also wants to hear from medical professionals about any information they may have about Trasylol.

News Image
over the past many years, Trasylol was given to as many as a third of all heart bypass patients in the United States

Americas Watchdog & its Corporate Whistle Blower Center are initiating a national investigation involving possible victims of the drug Trasylol. The pharmaceutical Trasylol, and its maker Bayer have been the subject of recent national news media coverage regarding deaths or injuries that may have resulted from this drugs use. Numerous lawsuits and or class action lawsuits have been filed against Bayer the drugs maker in the United States. It has been alleged that this drug may cause death, kidney failure or may have other possible serious side affects. It has also been alleged that Trasylol's manufacturer may have known about these possible side affects for a number of years.

Americas Watchdog & its Corporate Whistle Blower Center are national advocasy groups focused on consumer protection and corporate fair play ( http://AmericasWatchdog.Com ). According to Americas Watchdog, "our group intends to find out if there were issues with Trasylol, our group intends to find out who knew what, and our group intends make sure something like this never happens again".

Numerous class action lawsuits and or individual lawsuits have been filed over Trasylol's possible side affects. ( Including Case Number 00628, Court of Common Pleas, Philadelphia, County, PA, December 2006)

According to the Corporate Whistle Blower Center, "over the past many years, Trasylol was given to as many as a third of all heart bypass patients in the United States". A study in January 2006 linked the use of Trasylol with increased death risk and sugested 22,000 lives could have been saved if the medicine was recalled, According to a noted researcher, the German drugmaker Bayer had conducted its own research and confirmed the possible dangers, but failed to disclose to the FDA during an FDA advisory panel meeting in September 2006. Dr. William Hiatt, the chair of the FDA advisory panel, told CBS 60 minutes, he would have voted to remove Trasylol from the market had he known that Bayer had confirmed the findings.

Americas Watchdog and its Corporate Whistle Blower Center ( Http://AmericasWatchdog.Com ) wants to hear from any patient who used Trasylol, and possible victim of the drug called Trasylol, or any victims family who may have suffered a side affect from the drug manufacturing giant Bayer and their medication called Trasylol. Representatives at the Corporate Whistle Blower Center are available 24-7 at 866-714-6466.

Americas Watchdog would also like to hear from medical professionals who might have specific experience with the drug Trasylol or generic type alternative drugs that were available at a fraction of the cost with no side affects.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

THOMAS MARTIN
Visit website